CASI Pharmaceuticals Inc (NASDAQ:CASI)
| 1.62 Delayed Data As of 2:56pm ET |  -0.1089 / -6.30%Today’s Change | 1.45 Today|||52-Week Range 10.30 | -9.50% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $20.8M |
Company Description
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.
Contact Information
CASI Pharmaceuticals, Inc. 9620 Medical Center Drive Rockville Maryland 20850 |
Employees
Shareholders
| Mutual fund holders | 9.56% |
| Other institutional | 2.57% |
| Individual stakeholders | 2.35% |
Top Executives
| There are no executives to display. |
